Clinical Trial Update: Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating anecortave acetate for treatment of steroid-induced intraocular pressure elevation; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Alcon Research | Conditions: Eye Diseases | Phase 2 | Status: COMPLETED